Clinical Trial Update: Impact of Tomotherapy on Xerostomia and Quality of Life of Patients With Cancer of the Upper Aero-digestive Tract [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating tomotherapy for reducing xerostomia and improving quality of life in head and neck cancer patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Head and Neck Cancer, Radiotherapy by Tomotherapy Exclusive | Phase 2 | Status: TERMINATED